Nura Bio
4 known investors
Nura Bio is a biotech company developing therapies for neurological disorders by targeting pathways underlying axon degeneration and neuroimmune regulation to preserve neuronal integrity. It focuses on drug discovery aimed at altering the course of neurological diseases.
Investors · 4
Also in the syndicate · 1
Euclidean Capital
Funding
SEC filings, press & company announcements$73.8M disclosed across 1 of 3 rounds · 2024–2026
- $73.8MSeries BJun 2026 · 3 sources
The Column Group (lead), Euclidean Capital, Samsara BioCapital, Sanofi Ventures
Source ↗ - Undisclosed amountSeries ASep 2024Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Nura Bio do?
- Nura Bio is a biotech company developing therapies for neurological disorders by targeting pathways underlying axon degeneration and neuroimmune regulation to preserve neuronal integrity. It focuses on drug discovery aimed at altering the course of neurological diseases.
- Who are Nura Bio's investors?
- Nura Bio's investors include Samsara BioCapital, Sanofi Ventures, The Column Group.
- How much funding has Nura Bio raised?
- Nura Bio has disclosed $73.8M raised across 1 of its 3 known rounds.